4.7 Review

Modulation of defensive behavior by Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channels

期刊

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
卷 46, 期 -, 页码 418-428

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2014.03.026

关键词

Endovanilloids; Endocannabinoids; Anandamide; nxiety; Fear

资金

  1. CNPq PhD fellowship [290008/2009-3]
  2. FAPEMIG [APQ-01883-10, APQ-01038-11, PRONEM: APQ-04625-10]
  3. FAPESP [2012/17626-7]
  4. CAPES

向作者/读者索取更多资源

The Transient Receptor Potential Vanilloid Type-1 (TRPV1) was first characterized in primary afferent fibers as a receptor for capsaicin (the pungent ingredient of chili peppers). Later on, this cation-permeable ion channel was also described in the central nervous system, where its main putative endogenous ligand is N-arachidonoyl ethanolamide (an endocannabinoid, also known as anandamide). Recent results employing genetic, pharmacological and histochemical techniques indicate that TRPV1 tonically modulate anxiety, fear and panic responses in brain regions related to defensive responses, such as the dorsal periaqueductal gray, the hippocampus and the medial prefrontal cortex. Genetic deletion or antagonism of this ion channel induces anxiolytic-like effects in several animal models. The main mechanism responsible for TRPV1-mediated effects on anxiety seems to involve facilitation of glutamatergic neurotransmission. In addition, there is evidence for interactions with other neurotransmitter systems, such as nitric oxide and endocannabinoids. (C) 2014 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Neurosciences

The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol

Alice Hartmann, Carla Vila-Verde, Francisco S. S. Guimaraes, Samia R. Joca, Sabrina F. F. Lisboa

Summary: Many psychiatric patients do not respond to conventional therapy, and there is increasing interest in investigating the involvement of inflammatory mechanisms. Microglia dysfunction, particularly through the NLRP3 inflammasome pathway, has been implicated in neuropsychiatric disorders. Cannabidiol (CBD) has anti-inflammatory effects and can attenuate stress response and microglia activation. This review focuses on neuroinflammation, microglia involvement, and the potential effects of CBD on stress-related psychiatric disorders through NLRP3 inflammasome modulation.

CURRENT NEUROPHARMACOLOGY (2023)

Review Neurosciences

Effects of β-caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction

Laila Asth, Leonardo Cardoso Cruz, Nicholas Soyombo, Pedro Rigo, Fabricio A. Moreira

Summary: This study investigates the potential of beta-caryophyllene (BCP) as a new drug for the treatment of substance use disorders in animal models. The results show that BCP can prevent or reverse behavioral changes resulting from drug exposure. The mechanism involves activation of the CB2 receptor and potentially other targets. Further research, including studies in humans, is needed to establish its therapeutic potential and mechanisms of action.

CURRENT NEUROPHARMACOLOGY (2023)

Article Neurosciences

TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus

Lia P. Iglesias, Heliana B. Fernandes, Aline S. de Miranda, Malena M. Perez, Lucia H. Faccioli, Carlos A. Sorgi, Leandro J. Bertoglio, Daniele C. Aguiar, Carsten T. Wotjak, Fabricio A. Moreira

Summary: This study found that hippocampal TRPV1 channels play a role in the modulation of fear memories. Endocannabinoid signaling may mediate the effects of TRPV1 blockers. The intensity of the aversive stimulus affects the regulation of fear memories by TRPV1 channels. TRPV1 blockers also promote the transcription of specific genes, leading to a decrease in fear memory reinstatement.

NEUROPHARMACOLOGY (2023)

Article Neurosciences

Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors

Jaqueline M. Franzen, Isabel Werle, Felipe Vanz, Bruno Biscaia de Oliveira, Laura Maria Martins Nascimento, Francisco S. Guimaraes, Leandro J. Bertoglio

Summary: Growing evidence suggests that cannabidiol (CBD) modulates aversive memories and anxiety-related responses in females. This has therapeutic implications for treating anxiety and stress-related disorders in women. Studies in adult female rats show that CBD can attenuate the behavioral manifestations of learned fear and anxiety.

NEUROPHARMACOLOGY (2023)

Article Psychiatry

Levetiracetam Attenuates Adolescent Stress-induced Behavioral and Electrophysiological Changes Associated With Schizophrenia in Adult Rats

Andreza M. Cavichioli, Thamyris Santos-Silva, Anthony A. Grace, Francisco S. Guimaraes, Felipe Gomes

Summary: This study suggests that levetiracetam can attenuate the adverse outcomes associated with schizophrenia caused by stress during adolescence, by reversing the behavioral changes, ventral hippocampus hyperactivity, and enhanced ventral tegmental area dopamine system activity.

SCHIZOPHRENIA BULLETIN (2023)

Review Neurosciences

Role of Microglia in Psychostimulant Addiction

Maria Carolina Machado da Silva, Lia Parada Iglesias, Eduardo Candelario-Jalil, Habibeh Khoshbouei, Fabricio Araujo Moreira, Antonio Carlos Pinheiro de Oliveira

Summary: The use of psychostimulant drugs can modify brain function by affecting the reward system and altering dopaminergic and glutamatergic transmissions. Microglia and other immune cells may play a role in addiction by influencing neuroplasticity and memory. Recent studies have shown that psychoactive substances can directly affect immune cells, leading to changes in their functions and the release of inflammatory mediators that impact synaptic activity. Understanding the neuroimmune axis involved in addiction can provide potential targets for pharmacotherapy.

CURRENT NEUROPHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors

Danielle Diniz Aguiar, Cristina da Costa Oliveira, Flavia Cristina Sousa Fonseca, Douglas Lamounier de Almeida, William Valadares Campos Pereira, Francisco Silveira Guimara, Andrea Castro Perez, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romero

Summary: This study evaluated the analgesic effects of CBD when administered peripherally for the treatment of acute neuropathic pain, and investigated the involvement of the 5-HT1A and TRPV1 receptors. The results showed that CBD induced dose-dependent antinociceptive effects, with the highest potency observed at a dose of 30 mu g/paw. Furthermore, selective antagonists of the 5-HT1A and TRPV1 receptors partially reversed the antinociceptive effects of CBD.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Article Neurosciences

Contextual fear expression engages a complex set of interactions between ventromedial prefrontal cortex cholinergic, glutamatergic, nitrergic and cannabinergic signaling

Daniela Lescano Uliana, Cassiano Ricardo Alves Faria Diniz, Leandro Antero da Silva, Anna Barbara Borges-Assis, Sabrina Francesca Lisboa, Leonardo Barbosa Moraes Resstel

Summary: Rats re-exposed to a previously shocking environment display conditioned defensive responses, which are controlled by the ventromedial prefrontal cortex (vmPFC) and involve multiple neurotransmitter pathways. This study found that the administration of specific inhibitors and antagonists in the vmPFC prevented the increase in conditioned responses, suggesting the involvement of cholinergic, cannabinergic, and glutamatergic/nitrergic neurotransmissions.

NEUROPHARMACOLOGY (2023)

Article Clinical Neurology

Bed nucleus of the stria terminalis CB1 receptors and the FAAH enzyme modulate anxiety behavior depending on previous stress exposure

Anna Barbara Borges-Assis, Daniela Lescano Uliana, Sara Cristina Hott, Francisco Silveira Guimara, Sabrina Francesca Lisboa, Leonardo Barbosa Moraes Resstel

Summary: The endocannabinoid anandamide (AEA) can decrease the release of neurotransmitters by binding to presynaptic cannabinoid type 1 (CB1) receptors. AEA is hydrolyzed by the enzyme FAAH in the postsynaptic neuron. The present study investigated the role of AEA and CB1 receptors in the Bed Nucleus of the Stria Terminalis (BNST) in modulating anxiety-related behaviors. The findings suggest that eCB signaling in the BNST is recruited during aversive situations to counteract the stress effect.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Article Neurosciences

Effects of cannabidiol on reward contextual memories induced by cocaine in male and female mice

Rayssa C. Brianis, Lia P. Iglesias, Lucas G. Bedeschi, Fabricio A. Moreira

Summary: This study found that CBD did not decrease the reward memory involved in the formation of cocaine addiction. Further research is needed to investigate the involvement of CBD in other behavioral responses to cocaine and other psychostimulant drugs. However, this study characterized a 5-day CPP protocol for both female and male C57BL/6J mice.

ACTA NEUROPSYCHIATRICA (2023)

Article Neurosciences

The two synthetic cannabinoid compounds 4′-F-CBD and HU-910 efficiently restrain inflammatory responses of brain microglia and astrocytes

Mauricio dos Santos Pereira, Bruna Maitan Santos, Rocio Gimenez, Francisco Silveira Guimaraes, Rita Raisman-Vozari, Elaine Del Bel, Patrick Pierre Michel

Summary: Research found that 4'-F-CBD and HU-910, two synthetic cannabinoids, have anti-inflammatory potential and may have therapeutic utility in treating neuroinflammatory conditions.
Article Psychiatry

Transcriptomic analysis reveals mitochondrial pathways associated with distinct adolescent behavioral phenotypes and stress response

Thamyris Santos-Silva, Dogukan Hazar Ulgen, Caio Fabio Baeta Lopes, Francisco S. Guimaraes, Luciane Carla Alberici, Carmen Sandi, Felipe V. Gomes

Summary: Adolescent individuals show significant diversity in cortical dynamics and behavioral outcomes. The developing adolescent brain is sensitive to social experiences and environmental insults, which can influence the emergence of personality traits. Mitochondria play a crucial role in brain maturation and the development of mental illnesses, with specific mitochondrial features in certain brain regions accounting for behavioral differences in adulthood. This study investigates whether distinct adolescent behavioral phenotypes and the consequences of early adolescent stress exposure are associated with changes in PFC mitochondria-related genes and respiratory chain capacity.

TRANSLATIONAL PSYCHIATRY (2023)

Article Pharmacology & Pharmacy

The Reversal of Empathy-Induced Hypernociception in Male Mice by Intra-Amygdala Administration of Midazolam and Cannabidiol Depends on 5-HT3 Receptors

Ligia RenataRodrigues Tavares, Daniela Baptista-de-Souza, Lucas Canto-de-Souza, Cleopatra da Silva Planeta, Francisco Silveira Guimaraes, Ricardo Luiz Nunes-de-Souza, Azair Canto-de-Souza

Summary: Living with a partner experiencing chronic pain can lead to pain hypersensitivity and increased expression of 5-HT3 receptor and glutamic acid decarboxylase 67 in the amygdala. The anxiolytic benzodiazepine midazolam (MDZ) and cannabidiol (CBD) can attenuate this hypersensitive behavior, while the 5-HT3 receptor antagonist ondansetron can prevent their antinociceptive effects. These findings suggest that 5-HT3 receptor and GABAergic mechanisms in the amygdala play a role in pain hypersensitivity induced by empathy for pain, and that MDZ and CBD may be potential therapies for emotional pain disorders.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Pharmacology & Pharmacy

CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects

Pedro Henrique Gobira, Jacob LaMar, Jade Marques, Ariandra Sartim, Kennia Silveira, Luana Santos, Gregers Wegener, Francisco S. Guimaraes, Ken Mackie, Hui-Chen Lu, Samia Joca

Summary: This study investigates the involvement of cannabinoid type 1 receptors (CB1R) in the antidepressant and psychostimulant effects induced by ketamine. The results suggest that CB1R mediate the psychostimulant side effects of ketamine, but do not play a role in its antidepressant properties. Furthermore, pharmacological blockade of CB1R has similar antidepressant effects, but does not potentiate the effects of ketamine.

CANNABIS AND CANNABINOID RESEARCH (2023)

Review Pharmacology & Pharmacy

Effects of Δ9-THC and Type-1 Cannabinoid Receptor Agonists in the Elevated Plus Maze Test of Anxiety: A Systematic Review and Meta-Analysis

Lia P. Iglesias, Lucas Bedeschi, Daniele C. Aguiar, Laila Asth, Fabricio A. Moreira

Summary: Delta(9)-THC and related cannabinoids have complex effects on anxiety-like behavior in humans and experimental animals. This study reviews previous research and finds that cannabinoids tend to reduce anxiety-like behavior at low doses, but can increase anxiety at high doses.

CANNABIS AND CANNABINOID RESEARCH (2023)

Article Behavioral Sciences

Success versus failure in cognitive control: Meta-analytic evidence from neuroimaging studies on error processing

Edna C. Cieslik, Markus Ullsperger, Martin Gell, Simon B. Eickhoff, Robert Langner

Summary: Previous studies on error processing have primarily focused on the posterior medial frontal cortex, but the role of other brain regions has been underestimated. This study used activation likelihood estimation meta-analyses to explore brain activity related to committing errors and responding successfully in interference tasks. It was found that the salience network and the temporoparietal junction were commonly involved in both correct and incorrect responses, indicating their general involvement in coping with situations that require increased cognitive control. Error-specific convergence was observed in the dorsal posterior cingulate cortex, posterior thalamus, and left superior frontal gyrus, while successful responding showed stronger convergence in the dorsal attention network and lateral prefrontal regions. Underrecruitment of these regions in error trials may reflect failures in activating the appropriate stimulus-response contingencies necessary for successful response execution.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2024)